Tom Wilemon Archive — Page 3 of 39

September 18, 2025

Vanderbilt-developed AI platform validated for molecular mapping of tissues

The advancement transforms how scientists and clinicians can visualize and analyze complex tissues on a high-resolution map of cellular landscapes across entire tissue sections.

By Tom Wilemon
(AdobeStock)
September 17, 2025

Study reveals efficacy of nicotinamide for skin cancer prevention 

Overall, there was a 14% reduction in skin cancer risk. When nicotinamide was taken after a first skin cancer, the risk reduction rose to 54%.

By Tom Wilemon
September 12, 2025

Study shows magnesium inhibits colorectal cancer carcinogenesis by increasing vitamin D-synthesizing bacteria  

The findings from the current study suggest that magnesium also increases the gut synthesis of vitamin D, which does not go to the blood and takes effect locally.

By Tom Wilemon
The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
September 10, 2025

Vanderbilt-Ingram Cancer Center names associate directors and new program leaders 

Shared resources at Vanderbilt-Ingram are designed to support and enhance cancer-relevant research and scientific interaction by providing access to cutting-edge technologies and services, as well as scientific expertise.

By Tom Wilemon
September 8, 2025

SPORE grant funds $12 million for colorectal cancer research

SPORE grants are highly sought after because they show that a cancer center demonstrates scientific excellence, promotes collaboration, maintains robust research programs and merits substantial funding.

By Tom Wilemon
(photo by Erin O. Smith)
September 2, 2025

Vanderbilt-Ingram Cancer Center announces Young Adult Cancer Symposium

The symposium offers clinicians, patients, caregivers and advocates the opportunity to learn from internationally known experts focused on early-onset cancers.

By Tom Wilemon